Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3800-3810

  Hoft, Daniel F ^a,b   Farrar, Patricia L ^a   Kratz Owens, Katherine ^a   Shaffer, Dawn ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELL INVASION; HOST PARASITE INTERACTION; IMMUNE RESPONSE; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH MUCOSA; TRYPANOSOMA CRUZI;

EID: 0029757278     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3800-3810.1996     Document Type: Article

References (55)

1. Amato Neto, V., L. Matsubara, R. Campos, A. A. Moreira, P. L. Pinto, R. Faccioli, and M. Zugaib. 1992. Trypanosoma cruzi in the milk of women with chronic Chagas disease. Rev. Hosp. Clin. Fac. Med. Sao Paulo 47:10-11.
2. -) T lymphocytes. Infect. Immun. 57:2245-2248.
3. Beltz, L. A., F. Kierszenbaum, and M. B. Sztein. 1989. Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes. Infect. Immun. 57:2301-2305.
4. Beltz, L. A., M. B. Sztein, and F. Kierszenbaum. 1988. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes: Inhibition of IL-2 receptor expression. J. Immunol. 141:289-294.
5. Bittencourt, A. L., M. Sadigursky, A. A. Silva, C. A. S. Menezes, M. M. M. Marianetti, S. C. Guerra, and I. Sherlock. 1988. Evaluation of Chagas' disease transmission through breast-feeding. Mem. Inst. Oswaldo Cruz 83:37-39.
6. Brener, Z. 1973. Biology of Trypanosoma cruzi. Annu. Rev. Microbiol. 27:347-382.
7. Brener, Z. 1980. Immunity to Trypanosoma cruzi. Adv. Parasitol. 18:247-319.
8. Calvo Mendez, M. L., B. Nogueda Torres, and R. Alejandre Aguilar. 1992. La via oral: una puerta de acceso para Trypanosoma cruzi. Rev. Lat-amer. Microbiol. 34:39-42.
9. Camargo, E. P. 1964. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev. Inst. Med. Trop. Sao Paulo 6:93-100.
10. Choromanski, L., and R. E. Kuhn. 1989. Time-dependent mode of immunization augments suppressed antibody responses in spleen cell cultures from mice experimentally infected with Trypanosoma cruzi. Int. J. Parasitol. 19:935-938.
11. Choromanski, L., and R. E. Kuhn. 1990. Augmentation of suppressed anti-body responses in mice during experimental Chagas' disease by T helper cells activated in a time-dependent mode of immunization. J. Protozool. 37:388-392.
12. Czerkinsky, C. C., L.-A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid phase enzyme-linked immunospot (ELISPOT) assay for enumeration of antibody secreting cells. J. Immunol. Methods 65:109-122.
13. Dias, J. C. P. 1979. Mecanismos de transmissao, p. 152-174. In Z. Brener and Z. Andrade (ed.), Trypanosoma cruzi e Doenca de Chagas. Guanabara Koogan. Rio de Janeiro, Brazil.
14. Gus, I., M. E. Molon, and A. P. Bueno. 1993. Chagas disease - review of 8 simultaneous cases of acute Chagas myocarditis: 25 years later. Arq. Bras. Cardiol. 60:99-101.
15. Hayes, M. M., and F. Kierszenbaum. 1981. Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection. Infect Immun 31:1117-1124.
16. Hoft, D. F., R. G. Lynch, and L. V. Kirchhoff. 1993. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J. Immunol. 151:7038-7047.
17. Hoft, D. F., R. G. Lynch, and L. V. Kirchhoff. 1993. Unpublished data.
18. Kierszenbaum, F. 1989. Chagas' disease, p. 173-195. In F. Y. Liew (ed.), Vaccination strategies of tropical diseases. CRC Press, Boca Raton, Fla.
19. Kierszenbaum, F., W. R. Cuna, L. A. Beltz, and M. B. Sztein. 1989. Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components. J. Immunol. 143:275-279.
20. Kierszenbaum, F., W. R. Cuna, L. A. Beltz, and M. B. Sztein. 1990. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells. J. Immunol. 144:4000-4004.
21. Kirchhoff, L. V. 1995. Trypanosoma species (American trypanosomiasis, Chagas disease): biology of trypanosomes, p. 2442-2450. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York.
22. Kirchhoff, L. V., S. Hieny, M. Shiver, D. Snary, and A. Sher. 1984. Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi. J. Immunol. 133:2731-2735.
23. Kirchhoff, L. V., and D. F. Hoft. 1990. Immunization and challenge of mice with insect-derived metacyclic trypomastigotes of Trypanosoma cruzi. Parasite Immunol. 12:65-74.
24. Liew, F. Y., J. A. Schmidt, D. S. Liu, S. M. Millott, M. T. Scott, J. S. Dhaliwal, and S. L. Croft. 1988. Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. J. Immunol. 140:969-973.
25. Liew, F. Y., M. T. Scott, D. S. Liu, and S. L. Croft. 1987. Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. J. Immunol. 139:2452-2457.
26. Maggi, E., P. Biswas, G. F. Del Prete, P. Parronchi, D. Macchia, C. Simonelli, L. Emmi, M. De Carli, A. Tiri, M. Ricci, and S. Romagnani. 1991. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 146:1169-1174.
27. McCabe, R., S. Meagher, and B. Mullins. 1991. Gamma interferon suppresses acute and chronic Trypanosoma cruzi infection in cyclosporin-treated mice. Infect. Immun. 59:1633-1638.
28. McCabe, R. E., S. G. Meagher, and B. T. Mullins. 1991. Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi. J. Infect. Dis. 163:912-915.
29. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
30. McGhee, J. R., J. Mestecky, C. O. Elson, and H. Kiyono. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:175-199.
31. Miles, M. A. 1972. Trypanosoma cruzi-milk transmission of infection and immunity from mother to young. Parasitology 65:1-9.
32. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
33. Mosmann, T. R., J. H. Schumacher, N. F. Street, R. Budd, A. O'Garra, T. A. T. Fong, M. W. Bond, K. W. M. Moore, A. Sher, and D. F. Fiorentino. 1991. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 123:209-229.
34. Nabors, G. S., and R. L. Tarleton. 1991. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. J. Immunol. 146:3591-3598.
35. National Institutes of Health. 1995. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 273:376.
36. Nunes, M. P., S. G. Coutinho, J. A. Louis, and W. J. S. Souza. 1990. Trypanosoma cruzi: quantification tissues of experimentally infected mice by limiting dilution analysis. Exp. Parasitol. 70:186-192.
37. Parsonnet, J., S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke, E. Jellum, N. Orentreich, J. H. Vogelman, and G. D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1310-1311.
38. Plata, F., F. Wietzerbin, F. G. Pons, E. Falcoff, and H. Eisen. 1984. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur. J. Immunol. 14:930.
39. Reed, S. 1988. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 140:4342-4347.
40. Rowland, E. C., and R. E. Kuhn. 1978. Suppression of cellular responses in mice during Trypanosoma cruzi infections. Infect. Immun. 20:393-397.
41. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282.
42. Scott, P., E. Pearce, A. W. Cheever, R. L. Coffman, and A. Sher. 1989. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:161-182.
43. Shaw, J., R. Lainson, and H. Frahia. 1969. Consideracoes sobre a epidemiologia dos primeiros casos autocones de doenca de Chagas registrados em Belem, Para, Brasil. Rev. S. Publ. (Sao Paulo) 3:153-157.
44. Shikanai-Yasuda, M. A., C. B. Marcondes, L. A. Guedes, G. S. Sigueira, A. A. Barone, J. C. P. Dias, V. Amato Neto, J. E. Tolezano, B. A. Peres, E. R. Arruda, Jr., M. H. Lopes, M. Shiroma, and E. Chapadeiro. 1991. Possible oral transmission of acute Chagas disease in Brazil. Rev. Inst. Med. Trop. Sao Paulo 33:351-357.
45. Sullivan, J. J. 1982. Metacyclogenesis of Trypanosoma cruzi in vitro: a simplified procedure. Trans. R. Soc. Trop. Med. Hyg. 76:300-303.
46. Sztein, M. B., W. R. Cuna, and F. Kierszenbaum. 1990. Trypanosoma cruzi inhibits the expression of CD3, CD4, CDS, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes. J. Immunol. 144:3558-3562.
47. Tanowitz, H. B., D. Simon, J. P. Gumprecht, L. M. Weiss, and M. Wittner. 1990. Gastrointestinal manifestations of Chagas' disease, p. 56-75. In V. K. Rustgi (ed.), Gastrointestinal infections in the tropics. Karger, Basel.
48. Tarleton, R. L. 1988. Trypanosoma cruzi-induced suppression of IL-1 production. I. Evidence for the presence of IL-2-producing cells. J. Immunol. 140:2763-2768.
49. Tarleton, R. L. 1988. Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells. J. Immunol. 140:2769-2773.
50. 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature (London) 356:338-340.
51. Tarleton, R. L., and D. W. Scott. 1987. Initial induction of immunity, followed by suppression of responses to parasite antigens during Trypanosoma cruzi infection of mice. Parasite Immunol. 8:579-589.
52. Torrico, F., H. Heremans, M. T. Ribera, E. Van Marck, A. Billiau, and Y. Carlier. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 144:3626-3632.
53. WHO Expert Committee. 1991. Control of Chagas disease. WHO Technical Report Series 811. World Health Organization, Geneva.
54. Wirth, J. J., F. Kierszenbaum, G. Sonnenfeld, and A. Zlotnik. 1985. Enhancing effects of gamma Interferon on phagocytic cell association with and killing of Trypanosoma cruzi. Infect. Immun. 49:61.
55. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279.